Over Kanseri Tanısı Almış Hastaların Semptomlarının ve İyilik Halinin Değerlendirilmesi
Abstract
Objective: The aim of this study was to determine the symptoms of patients diagnosed with ovarian cancer in the Department of Obstetrics and
Gynecology, Ankara University Faculty of Medicine and to determine their well-being using standardized scales.
Materials and Method: This descriptive study was conducted in patients diagnosed with ovarian cancer at Ankara University Faculty of Medicine,
Department of Obstetrics and Gynecology. After the informed consent form was read and signed by the women who met the research criteria and
agreed to participate in the study, the data were collected face-to-face using the “Descriptive Characteristics Form” and “Nightingale Symptom
Assessment Scale (N-SAS)” questionnaires.
Results: The study included 100 women diagnosed with ovarian cancer. It was found that occupation, number of births, place of residence, social
security, cohabitants, and having a family history of cancer had a significant effect on the total scores of the N-SAS (p<0.05). When the subdimension
mean scores were examined, it was found that the mean score of psychological well-being was higher than the mean score of physical
well-being and social well-being.
Conclusion: A multidisciplinary team approach can contribute to the well-being of women with ovarian cancer through the curative and preventive
effects of care developed specifically for each individual. In order to improve physical, social and psychological health factors, it would be useful to
consider the factors we identified in our study.
Keywords
Ovary, cancer, symptoms, well-being
Ethical Statement
Approval for the research was obtained from the Ankara University Presidency Ethics Committee (decision no.: 16/183, date: 01.11.2021).
References
- 1. American Canser Society. Canser facts and figures 2018. [Erişim tarihi: 28.07.2022] Erişim linki: https://www.cancer.org/content/dam/cancerorg/ research/cancer-facts-and-statistics/annual-cancer-facts-andfigures/ 2018/cancer-facts-and-figures-2018.pdf
- 2. American Collage of Obstetricians ang Gynecologist. Overian cancer. FAQ096, April 2019. [Erişim tarihi: 28.07.2022] Erişim linki: https://www. acog.org/womens-health/faqs/ovarian-cancer
- 3. World Health Organization. International agency for research on cancer. Ovary globocan 2018. 28/07/2021 tarihinde http://gco.iarc.fr/today/data/ factsheets/cancers/25-Ovary-facts-sheet.pdf adresinden erişilmiştir..
- 4. Öğüt Düzen K, Korkmaz M. Kanser hastalarında, semptom kontrolü ve tamamlayıcı ve alternatif tıp kullanımı. Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi. 2015;8:67-76.
- 5. Sarı Şıra F. Kemoterapi alan onkoloji hastalarında semptomların değerlendirilmesi. Hemşirelik Programı Yüksek Lisans Tezi. Marmara Üniversitesi Sağlık Bilimleri Enstitüsü, İstanbul, 2007.
- 6. Karabulutlu Ö. Kemoterapi alan hastalarda semptom yönetimi ve yaşam kalitesinin sürdürülmesi. İstanbul Üniversitesi Florence Nightingale Hemşirelik Yüksekokulu Dergisi. 2009;17:218-225.
- 7. Tuncay S, Can Z, Kaplan S, et al. Over kanseri tanısı alan bir olguda cinsel sağlığın değerlendirilmesi. Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi. 2018;1:77-85.
- 8. Şahin N, editor. Güncel jinekoloji hemşireliği. Ankara: Akademisyen Kitabevi; 2019.
- 9. Evgin H. Over Kanseri Farkındalık Ölçeği (Ovarian Cancer Awareness Measure)’nin geçerlik ve güvenirlik çalışması/validity and reliability of ovarian cancer awareness measure. Yüksek Lisans Tezi. İstanbul Üniversitesi Lisansüstü Eğitim Enstitüsü, İstanbul, 2020.
- 10. Pekmezci Purut H, Genç Köse B, Akbal Y, et al. Kemoterapi alan kanser hastalarında görülen semptomlar ve tamamlayıcı terapi uygulamaları kullanımları. Sağlık Akademisyenleri Dergisi. 2022;9:211-219.